Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01736358 · ClinicalTrials.gov registry record · Phase 4
The Use of Intranasal Ketoralac for Pain Management (Sprix)
A Phase 4 study, sponsored by Montefiore Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT01736358 is a Phase 4 study that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 50 participants.
The verdict
NCT01736358, a Phase 4 study, was terminated before completion, sponsored by Montefiore Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
Despite an overall reduction in the perioperative complication rate, post operative pain management after ureteroscopic removal of stones (URS) remains a major factor delaying discharge of patients. The investigators hypothesize that perioperative usage of intranasal ketorolac will provide a reduction in post operative opioid requirements, better post operative pain control, higher anesthesia satisfaction and faster recovery.
Interventions
- DRUG Placebo
- DRUG Intranasal Ketoralac
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-10 |
| Est. Completion | 2014-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01736358
The ClinicalTrials.gov registry entry for NCT01736358 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01736358 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01736358 about?
NCT01736358 is a clinical study titled "The Use of Intranasal Ketoralac for Pain Management (Sprix)". Despite an overall reduction in the perioperative complication rate, post operative pain management after ureteroscopic removal of stones (URS) remains a major factor delaying discharge of patients. The investigators hypothesize that perioperative usage of intranasal ketorolac will provide a reducti...
What is the current status of trial NCT01736358?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2012-10. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01736358?
The interventions under investigation include: Placebo (DRUG), Intranasal Ketoralac (DRUG).
Who is sponsoring clinical trial NCT01736358?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.